In order to understand the importance of KRAS, PIK3CA and BRAF mutations for the progression of the various types of colorectal cancer, we compared the frequency of these oncogenic events in the series of polyps and in 50 MSI and 53 MSS CRC (Figure 1). This evidence concerns the gene PIK3CA and colorectal carcinoma.